Aclaris Therapeutics to Participate in Three November Healthcare Conferences
Rhea-AI Summary
Aclaris Therapeutics (NASDAQ: ACRS) will participate in three healthcare conferences in November 2025 with senior leadership presenting fireside chats.
Key events: Guggenheim on Nov 12, 2025 at 11:00 AM EST (Dr. Neal Walker et al.); Stifel on Nov 12, 2025 at 1:20 PM EST (Dr. Hugh Davis et al.); and Jefferies Global on Nov 17, 2025 at 2:00 PM GMT / 9:00 AM EST (Dr. Walker).
Live and archived webcasts will be available on the company Events page and accessible on the Aclaris website for at least 30 days.
Positive
- None.
Negative
- None.
News Market Reaction – ACRS
In the Oct 29 session, ACRS declined 2.09%, reflecting a moderate negative market reaction. Argus tracked a peak move of +9.5% during that session. Our momentum scanner triggered 10 alerts that day, indicating notable trading interest and price volatility.
Data tracked by StockTitan Argus on the day of publication.
AI-generated analysis. How Rhea-AI works. Not financial advice.
WAYNE, Pa., Oct. 29, 2025 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage biopharmaceutical company focused on developing novel product candidates for immuno-inflammatory diseases, today announced that the Company will participate in three upcoming healthcare conferences in November.
- On Wednesday November 12, 2025, at 11:00 AM EST, Aclaris’ Chief Executive Officer Dr. Neal Walker and other members of Aclaris’ senior leadership team will participate in a fireside chat during the Guggenheim 2nd Annual Healthcare Conference in Boston, MA.
- On Wednesday November 12, 2025, at 1:20 PM EST, Aclaris’ President and Chief Operating Officer Dr. Hugh Davis and other members of Aclaris’ senior leadership team will participate in a fireside chat during the Stifel 2025 Healthcare Conference in New York, NY.
- On Monday November 17, 2025, at 2:00 PM GMT (9:00 AM EST), Dr. Walker will participate in a fireside chat during the Jefferies Global Healthcare Conference in London, UK.
Live and archived webcasts of these events will be accessible on the Events page of https://www.aclaristx.com/. The webcasts will be available on the Aclaris website for at least 30 days.
About Aclaris Therapeutics, Inc.
Aclaris Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing a pipeline of novel product candidates to address the needs of patients with immuno-inflammatory diseases who lack satisfactory treatment options. The company has a multi-stage portfolio of product candidates powered by a robust R&D engine. For additional information, please visit www.aclaristx.com and follow Aclaris on X (formerly Twitter) at @AclarisTx and on LinkedIn.
Aclaris Therapeutics Contact:
Will Roberts
Senior Vice President
Corporate Communications and Investor Relations
(484) 329-2125
wroberts@aclaristx.com
